Effective Technology Transfers For Mammalian-Derived Biologics

Technical transfers are one of the most critical, yet challenging steps in the drug development process. If product and process knowledge is not exchanged correctly and efficiently, it could result in significant delays and failures. Therefore, an effective strategy is essential to accelerate the translation of projects from bench to market.

As a leader of technology transfer activities in the industry, Lonza understands the challenges associated with this critical step. Thus, our team has designed a modular, yet flexible approach to tech transfers that can successfully support progression from product development to clinical trials and, ultimately, commercialization. It is consistently structured and documented globally across all Lonza sites, so the experience is the same, regardless of which facility the transfer takes place. Download this paper for a detailed overview of Lonza’s tech transfer strategy for mammalian-derived biologics.